What are the most effective antifungal treatments for common pediatric fungal infections. How do different antifungal medications compare for treating diaper rash, oral thrush, and other fungal skin conditions in infants and children. Which antifungal creams and oral medications are recommended for various types of fungal rashes in babies.

Understanding Fungal Infections in Infants and Children

Fungal infections are a common concern in pediatric medicine, particularly affecting infants and young children. These infections can manifest in various forms, including diaper rash, oral thrush, and skin conditions. Understanding the nature and prevalence of these infections is crucial for effective treatment.

Candida albicans is often the culprit behind many fungal infections in children. This opportunistic yeast can thrive in warm, moist environments, making diaper areas particularly susceptible. Studies have shown that Candida is present in up to 80% of diaper rash cases that persist for more than three days.

Common Types of Fungal Infections in Pediatrics

• Diaper rash (candidal dermatitis)
• Oral thrush
• Tinea infections (ringworm)
• Onychomycosis (fungal nail infections)
• Tinea capitis (scalp ringworm)

Early recognition and appropriate treatment of these infections are essential to prevent complications and ensure the comfort of the child. Healthcare providers must be familiar with the various antifungal agents available and their specific applications in pediatric care.

Antifungal Creams for Diaper Rash: Efficacy and Safety

Diaper rash is a common condition affecting infants and toddlers, often exacerbated by fungal overgrowth. Antifungal creams play a crucial role in treating persistent diaper rash that has a fungal component. But which antifungal creams are most effective and safe for use on delicate baby skin?

Nystatin cream has long been a staple in treating candidal diaper dermatitis. It works by disrupting the cell membranes of Candida yeast, effectively killing the fungus. Studies have shown nystatin to be both safe and effective, with minimal systemic absorption when applied topically.

Miconazole is another popular antifungal agent used in diaper rash creams. It belongs to the azole class of antifungals and works by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes. A randomized, multicenter study comparing miconazole gel to nystatin suspension for oral candidiasis in infants found miconazole to be equally effective and well-tolerated.

Comparing Top Antifungal Creams for Diaper Rash

When selecting an antifungal cream for diaper rash, consider factors such as the severity of the infection, any previous allergic reactions, and the child’s overall health. Always consult with a pediatrician before starting any new treatment regimen.

Oral Thrush in Infants: Treatment Options and Considerations

Oral thrush is a common fungal infection in infants, characterized by white patches on the tongue, inner cheeks, and gums. While it can resolve on its own in some cases, treatment is often necessary to alleviate symptoms and prevent spread. What are the most effective antifungal treatments for oral thrush in babies?

Historically, gentian violet was one of the first treatments used for oral thrush. However, its use has declined due to potential side effects and staining. Modern treatments focus on more targeted antifungal medications that are safer and more effective.

Nystatin suspension remains a first-line treatment for oral thrush in infants. It is applied directly to the affected areas and is not significantly absorbed into the bloodstream, making it a safe option for young children. A study by Huang et al. in 1957 demonstrated the therapeutic efficacy of nystatin in treating oral moniliasis in infants.

In cases where nystatin is ineffective, fluconazole may be prescribed. Fluconazole is an oral antifungal that can be particularly useful for persistent or severe cases of thrush. A review by Grant and Clissold in 1990 highlighted fluconazole’s potential in treating superficial and systemic mycoses, including oral thrush in pediatric patients.

Comparing Oral Thrush Treatments for Infants

1. Nystatin suspension: Applied topically, minimal systemic absorption
2. Miconazole gel: Effective alternative to nystatin, may be better tolerated by some infants
3. Fluconazole: Oral medication for persistent cases, requires careful dosing
4. Amphotericin B: Used in severe cases or when other treatments fail

When treating oral thrush in infants, it’s crucial to consider the ease of application, potential side effects, and the likelihood of compliance. Parents should be educated on proper administration techniques to ensure optimal treatment outcomes.

Innovative Approaches to Treating Persistent Fungal Infections in Children

While most fungal infections in children respond well to standard treatments, some cases prove persistent or recurrent. In these situations, healthcare providers may need to consider innovative approaches or combinations of therapies. What cutting-edge treatments are showing promise for stubborn fungal infections in pediatric patients?

One innovative approach involves the use of probiotics in conjunction with antifungal treatments. Probiotics can help restore the natural balance of microorganisms in the body, potentially reducing the recurrence of fungal overgrowth. A study by Mansour and Gelfand in 1981 suggested a new approach to using antifungal agents in children with persistent oral candidiasis, highlighting the need for tailored treatment strategies.

Another area of innovation is the development of novel drug delivery systems. Researchers are exploring ways to enhance the efficacy of existing antifungal medications through improved formulations. For example, liposomal preparations of amphotericin B have shown promise in treating systemic fungal infections with reduced toxicity compared to conventional formulations.

Emerging Treatments for Pediatric Fungal Infections

• Combination therapy with probiotics and antifungals
• Liposomal drug delivery systems
• Targeted photodynamic therapy for superficial infections
• Immunomodulatory agents to enhance the body’s natural defenses
• Nanotechnology-based antifungal formulations

While these innovative approaches show promise, it’s important to note that many are still in the research phase and may not be widely available for clinical use. Healthcare providers should stay informed about emerging treatments and consider their potential applications in challenging cases.

Topical vs. Systemic Antifungal Treatments: Making the Right Choice

When treating fungal infections in children, healthcare providers must decide between topical and systemic antifungal treatments. This decision is crucial as it impacts the efficacy of the treatment, potential side effects, and the child’s overall experience. How do clinicians determine whether to use a topical cream or an oral medication for pediatric fungal infections?

Topical antifungals are generally the first line of defense for superficial fungal infections. They offer the advantage of direct application to the affected area with minimal systemic absorption. This localized approach often results in fewer side effects and is particularly suitable for conditions like diaper rash or mild cases of tinea infections.

Systemic antifungals, administered orally or intravenously, are reserved for more severe or widespread infections. They are often necessary for conditions like persistent oral thrush, tinea capitis, or when topical treatments have failed. Systemic treatments can reach areas that topical applications cannot, making them effective for deep or internal fungal infections.

Factors Influencing the Choice Between Topical and Systemic Treatments

1. Severity and extent of the infection
2. Location of the infection (e.g., skin surface vs. nail bed)
3. Patient’s age and overall health status
4. Potential for drug interactions or side effects
5. History of previous treatments and their efficacy

A study by Gupta et al. in 1998 provided an overview of topical antifungal therapy in dermatomycoses, offering insights into the effectiveness of various topical treatments. For systemic treatments, research by Brautigam in 1998 compared oral terbinafine and itraconazole for onychomycosis, demonstrating the efficacy of systemic antifungals for certain conditions.

Ultimately, the choice between topical and systemic antifungal treatments should be made on a case-by-case basis, considering the specific needs of the pediatric patient and the characteristics of the fungal infection being treated.

Long-term Management of Recurrent Fungal Infections in Children

Recurrent fungal infections can be a persistent challenge in pediatric care, requiring a comprehensive approach to long-term management. How can healthcare providers and parents work together to prevent and manage recurrent fungal infections in children effectively?

The key to managing recurrent fungal infections lies in identifying and addressing underlying factors that may contribute to the problem. This may include assessing the child’s immune function, evaluating environmental factors, and considering potential dietary influences.

Prophylactic use of antifungal medications may be considered in some cases. For instance, children with recurrent tinea capitis might benefit from periodic use of antifungal shampoos. A study by Lange et al. in 1998 demonstrated the effectiveness of ketoconazole 2% shampoo in treating tinea versicolor, suggesting its potential for prophylactic use in susceptible individuals.

Strategies for Preventing Recurrent Fungal Infections

• Maintaining good hygiene practices
• Regular use of moisture-wicking fabrics in clothing
• Avoiding prolonged exposure to damp environments
• Proper foot care, including keeping feet dry and wearing breathable shoes
• Dietary modifications to support immune function
• Addressing any underlying medical conditions that may increase susceptibility

Parents play a crucial role in the long-term management of recurrent fungal infections. Education about proper hygiene, early recognition of symptoms, and consistent follow-up with healthcare providers are essential components of a successful management plan.

For children with recurrent diaper rash, a study by Rebora and Leyden in 1981 explored the connection between gastrointestinal carriage of Candida albicans and napkin dermatitis. This research highlights the importance of considering systemic factors in managing recurrent fungal skin infections in infants.

Antifungal Resistance: A Growing Concern in Pediatric Care

As with many antimicrobial agents, there is growing concern about the development of resistance to antifungal medications. This issue is particularly pertinent in pediatric care, where the long-term implications of resistant infections can be significant. What are the current trends in antifungal resistance, and how can healthcare providers address this challenge in treating pediatric fungal infections?

Antifungal resistance can develop through various mechanisms, including changes in the target site of the drug, increased efflux of the drug from fungal cells, or overexpression of the drug target. The overuse or misuse of antifungal medications can contribute to the development of resistance.

In pediatric care, the emergence of azole-resistant Candida species is a particular concern. A study by Grossman in 1988 highlighted the importance of appropriate treatment strategies for thrush, emphasizing the need for judicious use of antifungal agents to prevent resistance.

Strategies to Combat Antifungal Resistance

1. Proper diagnosis before initiating treatment
2. Use of appropriate dosing and duration of therapy
3. Combination therapy when indicated
4. Regular monitoring of local resistance patterns
5. Education of healthcare providers and parents on proper antifungal use
6. Development of new antifungal agents with novel mechanisms of action

Healthcare providers must stay informed about current resistance patterns and guidelines for antifungal use. The judicious use of antifungal agents, coupled with appropriate infection control measures, can help mitigate the risk of resistance development.

Research into new antifungal agents and treatment strategies is ongoing. For example, a study by De Backer et al. in 1998 compared terbinafine and itraconazole for onychomycosis, demonstrating the importance of exploring alternative treatments to address potential resistance issues.

By adopting a proactive approach to antifungal stewardship and staying abreast of the latest research, healthcare providers can help ensure the continued effectiveness of antifungal treatments in pediatric care.

Antifungal agents for common paediatric infections

1. Kozninn PJ, Taschdjian CL, Weiner H. Incidence and pathogenesis of neonatal candidiasis. Pediatrics. 1958;21:421. [PubMed] [Google Scholar]

2. Kozninn PJ, Taschdjian CL, Dragutsky D, et al. Cutaneous candidiasis in early infancy and childhood. Pediatrics. 1957;20:827–34. [PubMed] [Google Scholar]

3. Bound JP. Thrush napkin rashes. Br Med J. 1956;i:782–4. [PMC free article] [PubMed] [Google Scholar]

4. Faber HK, Dickey LB. The treatment of thrush with gentian violet. JAMA. 1925;85:900–1. [Google Scholar]

5. Huang NN, Sarria A, High RH.Therapeutic evaluation of nystatin and amphotericin in oral moniliasis in infants Antibiot Annu 1957–1958.195859–64. [PubMed] [Google Scholar]

6. Boon JM, Lafeber HN, ‘t Mannetje AH, et al. Comparison of ketoconazole suspension and nystatin in the treatment of newborns and infants with oral candidiosis. Mycoses. 1989;32:312–5. [PubMed] [Google Scholar]

7. Hoppe J. Treatment of oropharyngeal candidiasis in immunocompetent infants: A randomized multicenter study of miconazole gel vs nystatin suspension. The Antifungals Study Group. Pediatr Infect Dis J. 1997;16:288–93. [PubMed] [Google Scholar]

8. Mansour A, Gelfand EW. A new approach to the use of antifungal agents in children with persistent oral candidiasis. J Pediatr. 1981;98:161–2. [PubMed] [Google Scholar]

9. Grossman ER. Treatment of thrush. Pediatr Infect Dis J. 1988;7:303. [PubMed] [Google Scholar]

10. Alban J, Groel JT. Amphotericin B oral suspension in the treatment of thrush. Curr Ther Res Clin Exp. 1970;12:479–84. [PubMed] [Google Scholar]

11. Rebora A, Leyden JJ. Napkin (diaper) dermatitis and gastrointestinal carriage of Candida albicans. Br J Dermatol. 1981;105:551–5. [PubMed] [Google Scholar]

12. Dixon PN, Warin RP, English MP. Alimentary Candida alibicans and napkin rashes. Br J Dermatol. 1972;86:458–62. [PubMed] [Google Scholar]

13. Munz D, Powell KR, Pai CH. Treatment of candidal diaper dermatitis: A double-blind placebo-controlled comparison of topical nystatin with topical plus oral nystatin. J Pediatr. 1982;101:1022–5. [PubMed] [Google Scholar]

14. Ginsberg CM. Malassezia species. In: Long SS, Pickering LK, Prober CG, editors. Principles and Practice of Pediatric Infectious Diseases. New York: Churchill Livingston; 1997. pp. 1337–8. [Google Scholar]

15. Gupta AK, Einarson TR, Summerbell RC, Shear NH. An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs. 1998;55:645–74. [PubMed] [Google Scholar]

16. Lange DS, Richards HM, Guarnieri J, et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: A multicenter, randomized, double-blind, placebo controlled trial. J Am Acad Dermatol. 1998;39:944–50. [PubMed] [Google Scholar]

17. Ginsberg CM. Dermatophytes and other superficial fungi. In: Long SS, Pickering LK, Prober CG, editors. Principles and Practice of Pediatric Infectious Diseases. New York: Churchill Livingston; 1997. pp. 1359–62. [Google Scholar]

18. Gupta AK, Sibbald RG, Lynde CW, et al. Onychomycosis in children: Prevalence and treatment strategies. J Am Acad Dermatol. 1997;36:395–402. [PubMed] [Google Scholar]

19. Brautigam M. Terbibafine verus itraconazole: A controlled clinical comparison in onychomycosis of toenails. J Am Acad Dermatol. 1998;38:S53–6. [PubMed] [Google Scholar]

20. De Backer M, De Vroey C, Lesaffre E, Scheys I, De Keyser P. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: A double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day. J Am Acad Dermatol. 1998;38:S57–63. [PubMed] [Google Scholar]

21. Tanz RR, Stagl S, Esterly NB. Comparison of ketoconazole and griseofulvin for the treatment of tinea capitis in childhood: A preliminary study. Pediatr Emerg Care. 1985;1:16–8. [PubMed] [Google Scholar]

22. Tanz RR, Hebert AA, Esterly NB. Treating tinea capitis: Should ketoconazole replace griseofulvin? J Pediatr. 1988;112:987–91. [PubMed] [Google Scholar]

23. Gan VN, Petruska M, Ginsburg CM. Epidemiology and treatment of tinea capitis: Ketoconazole vs griseofulvin. Pediatr Infect Dis J. 1987;6:46–9. [PubMed] [Google Scholar]

24. Martinez-Roig A, Torres-Rodriguez JM, Bartlett-Coma A.Double-blind study of ketoconazole and griseofulvin in dermatophytoses Pediatr Infect Dis J198;737–40. [PubMed] [Google Scholar]

25. Grant SM, Clissold SP. Fluconazole: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs. 1990;39:877–916. [PubMed] [Google Scholar]

26. Gatti S, Marinaro C, Bianchi L, Nini G. Treatment of kerion with fluconazole. Lancet. 1991;338:1156. [PubMed] [Google Scholar]

27. Solomon BA, Collins R, Sharma R, et al. Fluconazole for the treatment of tinea capitis in children. J Am Acad Dermatol. 1997;37:274–5. [PubMed] [Google Scholar]

28. Lopez-Gomez S, Del Palacio A, Van Cutsem J, Soledad Cueteara M, Iglesias L, Rodriguez-Noriega A. Itraconazole vs griseofulvin in the treatment of tinea capitis: A double-blind randomized study in children. Int J Dermatol. 1994;33:743–7. [PubMed] [Google Scholar]

29. Legendre R, Esola-Macre J. Itraconazole in the treatment of tinea capitis. J Am Acad Dermatol. 1990;23:559–60. [PubMed] [Google Scholar]

30. Lukacs A, Korting HC, Lindner A. Successful treatment of griseofulvin-resistant tinea capitis in infants. Mycoses. 1994;37:451–3. [PubMed] [Google Scholar]

31. Elewski BE. Tinea capitis: itraconazole in Trichophyton tonsurans infection. J Am Acad Dermatol. 1994;31:65–7. [PubMed] [Google Scholar]

32. Greer DL. Treatment of tinea capitis with itraconazole. J Am Acad Dermatol. 1996;35:637–8. [PubMed] [Google Scholar]

33. Faergemann J, Zehender H, Denouel J, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250mg terbinafine orally once per day for four weeks. Acta Derm Venerol. 1993;73:305–9. [PubMed] [Google Scholar]

34. Ryder NS. The mechanism of action of terbinafine. Clin Exp Dermatol. 1989;14:98–100. [PubMed] [Google Scholar]

35. Haroon TS, Hussain I, Mahmood A, Nagi AH, Ahmad I, Zahid M. An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis. Br J Dermatol. 1992;126(Suppl 39):47–50. [PubMed] [Google Scholar]

36. Nejjam F, Zagula M, Cabiac MD, Guessous N, Humbert H, Lakhdar H. Pilot study of terbinafine in children suffering from tinea capitis: Evaluation of efficacy, safety and pharmacokinetics. Br J Dermatol. 1995;132:98–105. [PubMed] [Google Scholar]

37. Alvi KH, Iqbal N, Khan KA, Haroon TS, Hussain I, Aman S, et al. A randomized double-blind trial of the efficacy and tolerability of terbinafine once daily compared to griseofulvin once daily in treatment of tinea capitis. In: Shuster S, Jafary MH, editors. Royal Society of Medicine Services International Congress Series, no 205. London: Royal Society of Medicine Press Ltd; 1992. pp. 35–40. [Google Scholar]

38. Haroon TS, Hussain I, Aman S, et al. A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis. Br J Dermatol. 1996;135:86–8. [PubMed] [Google Scholar]

39. Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis. J Am Acad Dermatol. 1997;37:272–3. [PubMed] [Google Scholar]

40. Dragos V, Lunder M. Lack of efficacy of 6-week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children. Pediatr Dematol. 1997;14:46–8. [PubMed] [Google Scholar]

41. Allen HB, Honig PJ, Leyden JJ, McGinley KJ. Selenium sulfide: Adjunctive therapy for tinea captitis. Pediatrics. 1982;69:81–3. [PubMed] [Google Scholar]

42. Givens TG, Murray MM, Baker RC. Comparison of 1% and 2.5% selenium sulfide in the treatment of tinea capitis. Arch Pediatr Adolesc Med. 1995;149:808–11. [PubMed] [Google Scholar]

43. Albengres E, Le Louet H, Tillement JP. Systemic antifungal agents. Drug interactions of clinical significance. Drug Saf. 1998;18:83–97. [PubMed] [Google Scholar]

44. Howard RM, Frieden HJ. Dermatophyte infections in children. In: Aronoff SC, Hughes WT, Kohl HS, Prince A, editors. Advances in Pediatric Infectious Diseases. Vol. 14. St Louis: Mosby-Year Book; 1999. pp. 73–108. [Google Scholar]

Dealing with ringworm or nappy rash? Here’s how an antifungal cream ca

When you’re expecting a new baby or raising a toddler, you want them to be happy, comfortable and healthy.

Even though you do your best, some issues will arise despite careful attention. Troubles like nappy rash and fungal outbreaks known as ringworm are two issues that can affect your baby’s skin.

Fortunately, an antifungal cream can help.

What is Antifungal Cream?

First, it is important to note that some fungal infections will require the attention of a doctor.

For mild cases of ringworm or nappy rash, a multipurpose, natural antifungal cream can be used. It will help treat the issue because it contains antiseptic and has anti-inflammatory properties. The cream should relieve itching, irritation and redness when applied to the affected area.

The best antifungal creams include Hydrastis Canadensis root & rhizome extract (Golden seal) as the main active ingredients. These have both been used for many years as medicinal remedies.

Botani’s Phytoseptic, natural antifungal cream has been a go-to for parents for many years. One of its most popular uses is to treat ringworm and nappy rash.

If you’re not sure what skin issue you are seeing, here is some information about ringworm and nappy rash.

What is ringworm?

Although the name implies a ‘worm’ infestation, ringworm is a rash that is brought on by a fungal infection. It gets its name because it can appear in a ring-like shape on the skin.

A ringworm outbreak can be transferred human-to-human or from animal to human. It is contagious and is caused by mould-like parasites that live in the skin’s outer layers. These parasites can even travel from an object to a human in some cases.

The fungus that causes ringworm loves a warm climate and travels best through skin-to-skin contact. This is part of the reason why babies can end up with this ailment.

Ringworm can appear on the torso, buttocks, legs and arms. You may notice raised and/or overlapping red ‘rings’ on yourself or your baby. As mentioned, mild cases can usually be treated with an antifungal cream. If the infection doesn’t go away, consult a doctor.

Ringworm can be difficult to prevent. Aim to wash your hands, keep your fingernails short and be careful about where you and your child walk around barefoot. Try to avoid public toilets/change rooms, parks and public showers.

What is nappy rash?

Nappy rash happens to most babies and toddlers at some stage. It arises when skin becomes irritated by friction or the acidic content of the child’s bladder and bowel movements.

The best way to prevent nappy rash is to change your child’s nappy as soon as it has been used. However, sometimes you won’t notice they have ‘made a deposit’ or it will take you a while to find a place to change your child.

You will know it is nappy rash if the skin looks red and sore. There may even be flaking or breaks in the skin (ouch). It can also show up outside the creases of their legs where their nappy rubs.

Raisingchildren.net.au recommends you visit a GP about nappy rash if:

• the nappy rash hasn’t improved after a week
• there are has blisters, crusts or pimples
• your child is upset and isn’t sleeping
• your child has an unexplained fever
• The rash is spreading
• you spot inflammation, swelling or a scab at the end of their penis.

If you want to treat and prevent nappy rash, an antifungal cream can help. Other tips for prevention include:

• ensuring your child is properly clean after a nappy change
• allowing for some nappy free time
• reducing fluids before bed (to minimise long nights in a wet nappy).

Botani’s Phytoseptic Antifungal Skin Cream

At Botani, we created an antifungal skin cream with anti-itch, anti-inflammatory, soothing and anti-bacterial properties.

Phytoseptic is meticulously formulated using a blend of elite botanicals, including GoldenSeal and Lemon Scented Tea Tree Oil. It provides a natural approach to typical anti-fungal skin treatment, with the added benefits of anti-bacterial and anti-inflammatory efficacy.

This cream is scientifically proven to provide a significantly broader spectrum of biocidal activity than comparative commercial products. Most commercial anti-fungal products are inhibitory only, hence there is a persistence of complaints such as nappy rash and ringworm.

Treat ringworm, nappy rash and other fungal infections the natural way

Common fungal infections such as tinea and candida can also be treated with Botani’s Phytoseptic Antifungal Cream.

If you have been battling with fungal infections for years and have tried countless treatments, only to have the issue return every time, Botáni Phytoseptic Natural Antifungal Cream will stop this cycle.

Phytoseptic is a unique natural formulation specifically created to kill fungal infections. It guarantees a 99.9% kill factor on Tinea and Candida in just 30 minutes**. Listed by the TGA (Therapeutic Goods Administration), Phytoseptic is safe to use. It does exactly what it’s been formulated to do: Kill fungus and bacteria.

**Scientific in vitro suspension tests antifungal and antimicrobial efficacy. Silliker Microtech Laboratories Pty. Ltd., ref. 01038828 an, test sponsored by Botani Australia on the 4th April 2002. Note that controlled clinical trials of product effectiveness have not been conducted in humans.

Never tested on animals | Gentle on young skin | The natural solution to nappy rash, ringworm and other fungal infections. Order Botani’s Phytoseptic Antifungal Cream today.

Back to News

Preparations for the external treatment of allergies for children (ointments, creams, gels)

{{if type === ‘partner-stocks’}}

{{/if}}

{{/if}}
{{each list}}

${this}
{{if isGorzdrav}}

Delete

{{/if}}

{{/each}}

{{/if}}
Search by drug, disease, substance:
Vitamins, Quit smoking, Voltaren, Nurofen, Lymphomyosot

Home

Medicines

Diseases

Antiallergic

External treatment

Preparations for the external treatment of allergies for children (ointments, creams, gels)

{{each product}}
{{tmpl({prod:this. target, type: ”}) “#productGalleryItemTemplate”}}
{{/each}}

Delivery

16

Atopic dermatitis

5

internal treatment

1

Hormonal external preparations

6

Dermatitis

8

Dermatology

15

For problem skin

1

Medications for itchy skin

7

Medications for rashes and itching on the skin

7

For allergies to the sun

4

Psoriasis

3

Remedies for dermatitis for children

5

Remedy for oily skin for men

1

Facial care

1

Show all

By expiration date

12

Stock

8

Gel
6

Cream
10

Ointment
2

Emulsion
1

Germany
2

Russia
12

France
1

Switzerland
4

Leave without a prescription
16

Prescription leave
3

No sedative effect
4

Non-hormonal
4

During pregnancy and breastfeeding
3

Medicine
13

Back

Product Availability

Product Availability

Shipping Availability

Shipping Availability

Categories

Categories

Discounts

Sk liquids

Product form

Product form

Manufacturers

Manufacturers

Active ingredients

Active ingredients

Country of origin

Country of origin

Prescription

Prescription

Registered as

Registered as

90 008 Volume (ml)

Volume (ml)

Pick up today
19

Delivery

16

Atopic dermatitis

5

internal treatment

1

Hormonal external preparations

6

Dermatitis

8

Dermatology

15

For problem skin

1

Medications for itchy skin

7

Medications for rashes and itching on the skin

7

For allergies to the sun

4

Psoriasis

3

Remedies for dermatitis for children

5

Remedy for oily skin for men

1

Facial care

1

By expiration date

12

Stock

8

Gel
6

Cream
10

Ointment
2

Emulsion
1

Gistan
2

Komfoderm
6

Psilo Balm
1

Fenistil
4

Cynovit
1

Elidel
3

GlaxoSmith Kline Healthcare
4

Akrikhin
6

Glenmark
2

Meda Pharma
3

Pharmtek
1

Shtada
1

Dimetinden
5

Dimethindene maleate
1

Diphenhydramine
1

Methylprednisolone aceponate
4

Methylprednisolone aceponate + Urea
2

pimecrolimus
3

Germany
2

Russia
12

France
1

Switzerland
4

Leave without a prescription
16

Prescription leave
3

No sedative effect
4

Non-hormonal
4

During pregnancy and breastfeeding
3

Medicine
13

Sort:

by popularity
by name
by price increase
by price decrease

by popularity

+5 bonuses

– 20% for 2pack

Fenistil Gel 0. 1% 30 g

Manufacturer:
GlaxoSmith Kline Healthcare

Switzerland

Active ingredient (INN):

Dimetinden

from 317 ₽

With a short shelf life

Price:
450 ₽

529 ₽
15%

+6 bonuses

– 20% for 2pack

Fenistil Gel 0.1% 50 g

Manufacturer:
GlaxoSmith Kline Healthcare

Switzerland

Active ingredient (INN):

Dimetinden

from 439 ₽

With a short shelf life

Price:
611 ₽

719 ₽
15%

+4 bonuses

Psilo Balm Gel for external use 1% 20 g

Shtada

Country of origin:
Germany

Active ingredient (INN):

Diphenhydramine

Price:
395 RUB

493. 80 RUB
20%

+10 bonuses

Elidel Cream 1% 15 g

Meda Pharma

Producer country:
Germany

Active ingredient (INN):

Pimecrolimus

from 591 ₽

With a short shelf life

Price:
951 ₽

+6 bonuses

Comfoderm K for the treatment of dermatitis in adults and children Cream 0.1% 15 g

Manufacturer:
Akrikhin

Country of manufacture:
Russia

Active ingredient (INN):

Methylprednisolone aceponate

from 486 ₽

With a short shelf life

Price:
558 ₽

+7 bonuses

Comfoderm M2 Cream for external use 0. 1% + 2% 30 g

Manufacturer:
Akrikhin

Country of manufacture:
Russia

Active ingredient (INN):

Methylprednisolone aceponate + Urea

from 454 ₽

With a short shelf life

Price:
731 ₽

+4 bonuses

Phoenixmart gel 50 g

Glenmark

Country of manufacture:
Russia

Active ingredient (INN):

Dimetinden

Price:
404 ₽

449 ₽
10%

+3 bonuses

Phoenixmart gel 30 g

Manufacturer:
Glenmark

Country of manufacture:
Russia

Active ingredient (INN):

Dimetinden

Price:
278 ₽

309 ₽
10%

+16 bonuses

Elidel Cream for external use 1% 30g

Meda Pharma

Producer country:
France

Active ingredient (INN):

Pimecrolimus

from 692 ₽

With a short shelf life

Price:
1 571 ₽

+5 bonuses

Comfoderm for the treatment of dermatitis in adults and children Ointment 0. 1% 15 g

Manufacturer:
Akrikhin

Country of manufacture:
Russia

Active ingredient (INN):

Methylprednisolone aceponate

from 197 ₽

With a short shelf life

Price:
458 ₽

+7 bonuses

Cynovit Cream for problem skin care 40 ml

Pharmtek

Country of origin:
Russia

from 217 ₽

With a short shelf life

Price:
369 ₽

+6 bonuses

Gistan – Zinc Pyrithione Cream 50 ml

VIS

Country of origin:
Russia

Price:
299 ₽

352 ₽
15%

+8 bonuses

Comfoderm K for the treatment of dermatitis in adults and children Cream 0. 1% 30 g

Manufacturer:
Akrikhin

Country of manufacture:
Russia

Active ingredient (INN):

Methylprednisolone aceponate

from 724 ₽

With a short shelf life

Price:
816 ₽

+7 bonuses

Gistan Cream for external use 0.1% 50 ml

VIS

Country of origin:
Russia

Price:
336 ₽

395 ₽
15%

+9 bonuses

– 20% for 2 pack

Fenistil Gel 0.1% 100 g

Manufacturer:
GlaxoSmith Kline Healthcare

Country of manufacture:
Switzerland

Active ingredient (INN):

Dimetinden

from 619 ₽

With a short shelf life

Price:
866 RUB

1,082. 50 RUB
20%

+4 bonuses

Comfoderm M2 Cream for external use 0.1% + 2% 10 g

Manufacturer:
Akrikhin

Country of manufacture:
Russia

Active ingredient (INN):

Methylprednisolone aceponate + Urea

from 263 ₽

With a short shelf life

Price:
440 ₽

+7 bonuses

Comfoderm for the treatment of dermatitis in adults and children Ointment 0.1% 30 g

Manufacturer:
Akrikhin

Country of manufacture:
Russia

Active ingredient (INN):

Methylprednisolone aceponate

from 313 ₽

With a short shelf life

Price:
704 ₽

+6 bonuses

– 20% for 2pack

Fenistil emulsion 0. 1% 8 ml

GlaxoSmith Kline Healthcare

Switzerland

Active ingredient (INN):

Dimethindene maleate

Price:
606 ₽

+37 bonuses

Elidel Cream for external use 1% 100 g

Manufacturer:
Meda Pharma

Country of manufacture:
Russia

Active ingredient (INN):

Pimecrolimus

Price:
3 697 ₽

Allergic skin diseases in children

External treatment of allergic diseases in children

Allergic diseases in childhood are not uncommon. Eczema, food allergies, allergic dermatitis, diathesis, urticaria, pruritus, atopic dermatitis – this is not a complete list of what a child of even a very young age can suffer from. Among these diseases, the most persistent and difficult to treat is atopic dermatitis. Its mandatory treatment is the guarantee of skin health for life. Well and competently treated at an early age, it can disappear by 3 years forever. But even older children should not give up.

In treatment, internal remedies are always combined with external ones. In this publication, I will focus on the features of external treatment.

In recent years, corticosteroid (hormonal) ointments have taken the leading place among the external therapy of atopic dermatitis, pushing other drugs aside. Every doctor knows the names of corticosteroid ointments, and the question is no longer whether to use them or not to use them. Rather, the choice of the most effective of them is carried out, with fewer side effects and the possibility of more or less long-term use. It often does not coincide with the financial capabilities of parents who, not seeing the difference between the drugs, choose a cheaper ointment. Without denying the undeniable benefits of corticosteroid ointments during an exacerbation, I want to note that none of them is suitable for long-term use, and an exacerbation can last for many months. In addition, there is no drug specifically designed for the treatment of children. In this regard, each dermatologist and pediatrician, in an effort to reduce the concentration of the medicinal substance applied to the skin of a sick child, uses his “home-made preparations”, which generally come down to mixing the finished drug with various creams, oils, solutions or other ointments. In this case, the dosage form of the drug is violated, which is highly undesirable, since its physicochemical and pharmacological properties change in this case.

We agree that it is difficult to do without glucocorticosteroid (hormonal) external preparations. But here are some quite typical situations that both the doctor and the parents of patients have to face during the treatment of atopic dermatitis in children:

• A short (usually 2 weeks) course of treatment with corticosteroid ointments has been completed – what to lubricate the skin further?
• Long-term treatment with corticosteroid ointments has led to addiction – which external agents should I switch to?
• Parents strongly refuse treatment with corticosteroid ointments (corticophobia is now a common phenomenon, and there are good reasons for it, because the permeability of the child’s skin is much higher than in adults, and corticosteroid ointments applied to it cannot but have a systemic effect – than their replace
• The long-awaited remission has come, but the skin remains dry and easily irritated – how to eliminate these phenomena?

To answer these questions, let’s consider what dermatologists have in the arsenal of external non-steroidal treatments for atopic dermatitis, and what tasks can be solved using the means of various groups. In the following, we present only finished medicinal products. The success of numerous medicinal prescriptions used in pediatric practice depends on the experience of the dermatologist and has not been proven by clinical trials.

Antimicrobial and antiseptic agents

Fukaseptol and Fukortsin (solutions for external use of 10 and 25 ml in vials) are similar in composition to a red liquid with a characteristic odor of aniline dye (magenta). Fukaseptol is manufactured using a new technology that allows you to keep the composition of the drug stable throughout the entire shelf life. The components of fucorcin during long-term storage may precipitate. Both drugs have an excellent antimicrobial and antifungal effect, without interfering with healing. They are used for application to crusts, places of combing, pustules. It is not recommended to lubricate fresh wounds, because. the alcohol in the composition causes a burning sensation. Large areas of skin should not be treated. After the solution has dried, pastes, ointments and creams can be applied to the skin.

Alcohol solution of methylene blue 1% has similar indications and application features. When applied to large areas of the skin, the urine of the child turns blue.

Hydrogen peroxide 3% causes stinging when applied to the skin but is always well tolerated. She treats fresh wounds and scratches.

Furacilin solution 0.02%, made from powder and 0.2 g tablets, belongs to another group of antiseptics – nitrofurans. Due to the weak action and frequent cases of increased inflammation, nitrofurans in the treatment of allergic diseases have given way to stronger antiseptics – halogen-containing (chlorhexidine – 0.05% solution of 100 ml per vial) and miramistin (0.01% solution of 100 ml per vial). .). Both solutions are aqueous, they can treat fresh wounds and scratches without risking causing pain in the child, however, aqueous solutions dry out for a long time, and the skin treatment process, which is always unpleasant for babies, is delayed.

Antibiotic ointments are used with caution in atopic dermatitis, as they are often allergenic. This group is dominated by domestic preparations, with the exception of Bactroban ointments (contains 2% mupirocin), Baneocin, Fucidin. Combined ointments Baneocin (contains bacitracin and neomycin), Levomekol ointment (contains chloramphenicol and methyluracil), Levosin ointment (contains chloramphenicol, methyluracil, sulfadimethoxin), in our experience, do not have any significant advantages. Unfortunately, the fatty base of domestic antibiotic ointments does not contribute to the drying and falling off of the crusts, rather softening them, so dermatologists prefer to use pastes with antibiotics (1% erythromycin, 2-5% lincomycin), manufactured by prescription in a pharmacy. Fusidin gel and Fucidin cream (contains 2% fusidic acid) has some advantage since there are still few resistant strains of microorganisms to the fusidic acid contained in the preparation.

Significantly better tolerated, although less commonly used, preparations of silver sulfathiazole – Argosulfan cream and ointment containing 2% silver sulfathiazole in tubes of 40 g, Dermazin cream, 1%, 50 g each, Sulfargin ointment in tubes of 50 g. should not be used in case of allergy to sulfanilamide and sulfur-containing drugs.

Bismuth preparations (dermatol ointment 10%, xeroform ointment 10%) are inexpensive domestic preparations that have an excellent effect (antiseptic, drying and anti-inflammatory), however, they have a sharp unpleasant odor and are rarely found in pharmacies.

Skin-cap preparations (70 and 100 ml aerosol, 50 g cream) also combine antiseptic and anti-inflammatory properties, high cost limits their wide application.

Anti-inflammatory and antipruritic drugs

ASD paste 5% is an excellent drug that successfully competes with corticosteroid ointments in terms of its strength. It used to be possible to make it in a pharmacy with a prescription, but due to the strong unpleasant smell and the reduction in the number of manufacturing pharmacies, this is now very difficult to do.

Elidel (contains pimecrolimus, 1% cream at 15.30 and 100 g) is a relatively new anti-inflammatory drug that prevents the production and release of biologically active substances from lymphocytes and mast cells (involved in cell inflammation). Can be used in children from 3 months of age. Use is contraindicated in case of infection of rashes (the appearance of pustules, crusts, weeping), it is not recommended to combine with other external agents. The use of the drug is limited by its high cost.

Preparations containing zinc oxide (suspension Zindol zinc paste and ointment) have a moderate anti-inflammatory and drying effect, but are widely used in pediatric practice, since they almost never cause side effects, are cheap and available.

Ichthyol ointment 10 and 20% – a drug with a moderate anti-inflammatory and resolving effect, is used in a period when acute inflammation is behind, and skin density is maintained. The action of the ointment is enhanced by the application of occlusive dressings (compress paper or a piece of cellophane is placed on top of the ointment and covered with a bandage), they also prevent soiling of linen in the dark brown color characteristic of this ointment.

Naftaderm (10% Naftalan oil liniment in tubes of 35 g) is an anti-inflammatory, antipruritic, analgesic, wound healing drug, which also has the property of enhancing the effect of other externally applied agents, therefore it is usually used in combination with other external preparations. Its disadvantage is a specific oil smell.

Ointments related to non-steroidal anti-inflammatory drugs (indomethacin ointment 10% and gel 5% and 10%, Butadion 5%, etc.) are rarely used for treatment, as they are not effective enough and sometimes cause allergic skin reactions.

Lead water or lotion (0.5% lead acetate solution – 100 ml per vial) is one of the old ways to relieve acute inflammation. Other preparations for lotions in finished form are not currently available.

Topical antihistamines such as Fenistil (gel 1% in tubes of 20 and 30 g) are unfortunately not often effective in atopic dermatitis. They are useful in the first hours of an exacerbation, as well as with concomitant urticaria or a hyperergic reaction to insect bites in the summer.

Healing agents that improve trophism and tissue regeneration

The group primarily includes preparations containing vitamin A (Videstim, Radevit, Redecyl ointments). Videstim ointment (containing 0. 5% retinol palmitate in an emulsion base, in tubes of 35 g) is specially provided for a low concentration of vitamin A, which makes it suitable for use in the youngest children. Ointment Radevit contains 3 fat-soluble vitamins – A, D and E (in tubes of 35 g), which act as synergists, that is, enhance each other’s action. They are used in the subacute and chronic phases of atopic dermatitis, as they do not have a pronounced anti-inflammatory activity.

Methyluracil ointment 10% – includes methyluracil as an immunomodulator and healing stimulator. This is a remedy with a moderate healing effect, which is partly due to its vaseline base, which prevents the active principle of the ointment from penetrating into the dermis. A new modern analogue, Stizamet ointment (contains 3% methyluracil on an emulsion basis in tubes of 35 g), is easily absorbed into the skin, while softening and moisturizing it, has a pronounced healing and immunomodulatory effect (improves skin immunity). Ointment Redecyl (combined preparation containing 1% retinol palmitate and 3% methyluracil on an emulsion basis in tubes of 35 g) combines the healing and immunomodulatory properties of both active substances included in it. It is specially designed for the treatment of allergic skin diseases. In addition, it turned out to be useful in restoring the skin after suffering an exacerbation and prolonged use of hormonal ointments.

Drugs containing dexpanthenol are often and successfully used in therapy. Aerosol Panthenol (130 ml each) and Bepanten (5% cream, 5% ointment in tubes of 30 g and 2.5% lotion of 200 ml) have a good and fast effect on combed skin areas.

Calf blood preparations are increasingly used by dermatologists and pediatricians (Actovegin cream 5% and ointment 5% in tubes of 20 g, Solcoseryl – gel 5% and ointment 5% in tubes of 20 g). Their therapeutic spectrum is rather narrow, in addition, dosage forms are changed as they heal, so the use is limited to the healing of cracks and scratches.

The range of softening and moisturizing products is not so wide, however, these are very necessary products that eliminate dry skin. They can be used in any phase of inflammation.